nodes	percent_of_prediction	percent_of_DWPC	metapath
Teniposide—Topoisomerase Inhibitors—Irinotecan—colon cancer	0.54	1	CiPCiCtD
Teniposide—lung cancer—colon cancer	0.28	1	CtDrD
Teniposide—ABCG2—Irinotecan—colon cancer	0.0186	0.173	CbGbCtD
Teniposide—ABCG2—Fluorouracil—colon cancer	0.0179	0.166	CbGbCtD
Teniposide—ABCG2—Vincristine—colon cancer	0.0163	0.152	CbGbCtD
Teniposide—CYP2C9—Capecitabine—colon cancer	0.0112	0.104	CbGbCtD
Teniposide—CYP3A5—Irinotecan—colon cancer	0.0103	0.0961	CbGbCtD
Teniposide—ABCG2—Methotrexate—colon cancer	0.00986	0.0918	CbGbCtD
Teniposide—CYP3A5—Vincristine—colon cancer	0.00902	0.084	CbGbCtD
Teniposide—CYP2C9—Fluorouracil—colon cancer	0.00664	0.0619	CbGbCtD
Teniposide—CYP3A4—Irinotecan—colon cancer	0.00402	0.0375	CbGbCtD
Teniposide—CYP3A4—Vincristine—colon cancer	0.00352	0.0328	CbGbCtD
Teniposide—Gastrointestinal toxicity—Capecitabine—colon cancer	0.00124	0.0375	CcSEcCtD
Teniposide—Cardiotoxicity—Fluorouracil—colon cancer	0.00123	0.0374	CcSEcCtD
Teniposide—NCOA3—Topotecan—Irinotecan—colon cancer	0.0012	0.746	CbGdCrCtD
Teniposide—Leukaemia—Vincristine—colon cancer	0.00116	0.0351	CcSEcCtD
Teniposide—Acute leukaemia—Irinotecan—colon cancer	0.00106	0.0322	CcSEcCtD
Teniposide—Electrocardiogram change—Fluorouracil—colon cancer	0.00102	0.0308	CcSEcCtD
Teniposide—Gastrointestinal toxicity—Methotrexate—colon cancer	0.000922	0.0279	CcSEcCtD
Teniposide—Neurotoxicity—Vincristine—colon cancer	0.000804	0.0244	CcSEcCtD
Teniposide—Myelosuppression—Vincristine—colon cancer	0.000665	0.0201	CcSEcCtD
Teniposide—NCOA1—bone marrow—colon cancer	0.000662	0.0691	CbGeAlD
Teniposide—NCOA1—vagina—colon cancer	0.000634	0.0662	CbGeAlD
Teniposide—NCOA3—smooth muscle tissue—colon cancer	0.000633	0.0661	CbGeAlD
Teniposide—Myelosuppression—Fluorouracil—colon cancer	0.00062	0.0188	CcSEcCtD
Teniposide—NCOA3—renal system—colon cancer	0.00061	0.0637	CbGeAlD
Teniposide—Sudden death—Irinotecan—colon cancer	0.000593	0.018	CcSEcCtD
Teniposide—Sudden death—Fluorouracil—colon cancer	0.000568	0.0172	CcSEcCtD
Teniposide—Leukaemia—Methotrexate—colon cancer	0.000562	0.017	CcSEcCtD
Teniposide—Mucosal inflammation—Irinotecan—colon cancer	0.000548	0.0166	CcSEcCtD
Teniposide—ABCC6—renal system—colon cancer	0.000536	0.056	CbGeAlD
Teniposide—NCOA1—liver—colon cancer	0.000535	0.0558	CbGeAlD
Teniposide—Neurotoxicity—Capecitabine—colon cancer	0.000524	0.0159	CcSEcCtD
Teniposide—NCOA3—lymphoid tissue—colon cancer	0.000506	0.0529	CbGeAlD
Teniposide—NCOA3—digestive system—colon cancer	0.0005	0.0522	CbGeAlD
Teniposide—Bone marrow depression—Vincristine—colon cancer	0.000462	0.014	CcSEcCtD
Teniposide—NCOA3—bone marrow—colon cancer	0.000461	0.0481	CbGeAlD
Teniposide—NCOA3—vagina—colon cancer	0.000442	0.0461	CbGeAlD
Teniposide—NCOA1—lymph node—colon cancer	0.00041	0.0428	CbGeAlD
Teniposide—Sudden death—Capecitabine—colon cancer	0.000397	0.012	CcSEcCtD
Teniposide—Neurotoxicity—Methotrexate—colon cancer	0.00039	0.0118	CcSEcCtD
Teniposide—NCOA3—liver—colon cancer	0.000373	0.0389	CbGeAlD
Teniposide—Mucosal inflammation—Capecitabine—colon cancer	0.000367	0.0111	CcSEcCtD
Teniposide—Extravasation—Vincristine—colon cancer	0.000357	0.0108	CcSEcCtD
Teniposide—Etoposide—PTGS2—colon cancer	0.000357	0.541	CrCbGaD
Teniposide—Extravasation—Irinotecan—colon cancer	0.000348	0.0105	CcSEcCtD
Teniposide—Extravasation—Fluorouracil—colon cancer	0.000333	0.0101	CcSEcCtD
Teniposide—Raised liver function tests—Methotrexate—colon cancer	0.000328	0.00993	CcSEcCtD
Teniposide—ABCC6—liver—colon cancer	0.000328	0.0342	CbGeAlD
Teniposide—Etoposide—ABCB1—colon cancer	0.000304	0.46	CrCbGaD
Teniposide—Bone marrow depression—Capecitabine—colon cancer	0.000301	0.00912	CcSEcCtD
Teniposide—Sudden death—Methotrexate—colon cancer	0.000296	0.00896	CcSEcCtD
Teniposide—Neuropathy—Vincristine—colon cancer	0.000293	0.00887	CcSEcCtD
Teniposide—NCOA3—lymph node—colon cancer	0.000286	0.0298	CbGeAlD
Teniposide—Neoplasm—Irinotecan—colon cancer	0.000274	0.00832	CcSEcCtD
Teniposide—Mucosal inflammation—Methotrexate—colon cancer	0.000273	0.00828	CcSEcCtD
Teniposide—TOP2A—bone marrow—colon cancer	0.00027	0.0282	CbGeAlD
Teniposide—Sepsis—Irinotecan—colon cancer	0.000263	0.00798	CcSEcCtD
Teniposide—TOP2A—vagina—colon cancer	0.000259	0.0271	CbGeAlD
Teniposide—Sepsis—Fluorouracil—colon cancer	0.000252	0.00764	CcSEcCtD
Teniposide—Bone marrow depression—Methotrexate—colon cancer	0.000224	0.00679	CcSEcCtD
Teniposide—Cyanosis—Methotrexate—colon cancer	0.000214	0.00647	CcSEcCtD
Teniposide—Neuropathy—Capecitabine—colon cancer	0.000191	0.00578	CcSEcCtD
Teniposide—Pancytopenia—Vincristine—colon cancer	0.000186	0.00563	CcSEcCtD
Teniposide—Neoplasm—Capecitabine—colon cancer	0.000184	0.00557	CcSEcCtD
Teniposide—Neutropenia—Vincristine—colon cancer	0.000183	0.00554	CcSEcCtD
Teniposide—Neutropenia—Irinotecan—colon cancer	0.000178	0.0054	CcSEcCtD
Teniposide—Sepsis—Capecitabine—colon cancer	0.000176	0.00534	CcSEcCtD
Teniposide—Extravasation—Methotrexate—colon cancer	0.000173	0.00525	CcSEcCtD
Teniposide—Pancytopenia—Fluorouracil—colon cancer	0.000173	0.00525	CcSEcCtD
Teniposide—CYP2C19—digestive system—colon cancer	0.000172	0.018	CbGeAlD
Teniposide—Phlebitis—Capecitabine—colon cancer	0.000171	0.00519	CcSEcCtD
Teniposide—Neuropathy peripheral—Vincristine—colon cancer	0.000171	0.00518	CcSEcCtD
Teniposide—Stomatitis—Vincristine—colon cancer	0.00017	0.00515	CcSEcCtD
Teniposide—Hepatic function abnormal—Capecitabine—colon cancer	0.000169	0.00511	CcSEcCtD
Teniposide—TOP2A—lymph node—colon cancer	0.000168	0.0175	CbGeAlD
Teniposide—Sweating—Vincristine—colon cancer	0.000167	0.00507	CcSEcCtD
Teniposide—Stomatitis—Irinotecan—colon cancer	0.000166	0.00502	CcSEcCtD
Teniposide—CYP3A5—renal system—colon cancer	0.000166	0.0173	CbGeAlD
Teniposide—TOP2A—Topotecan—Irinotecan—colon cancer	0.000164	0.103	CbGdCrCtD
Teniposide—Haemolytic anaemia—Capecitabine—colon cancer	0.000163	0.00495	CcSEcCtD
Teniposide—Sweating—Irinotecan—colon cancer	0.000163	0.00493	CcSEcCtD
Teniposide—Neuropathy peripheral—Fluorouracil—colon cancer	0.000159	0.00483	CcSEcCtD
Teniposide—Stomatitis—Fluorouracil—colon cancer	0.000159	0.0048	CcSEcCtD
Teniposide—Haemoglobin—Irinotecan—colon cancer	0.000153	0.00464	CcSEcCtD
Teniposide—Haemorrhage—Irinotecan—colon cancer	0.000152	0.00462	CcSEcCtD
Teniposide—CYP2C19—vagina—colon cancer	0.000152	0.0159	CbGeAlD
Teniposide—Haemoglobin—Fluorouracil—colon cancer	0.000147	0.00445	CcSEcCtD
Teniposide—Haemorrhage—Fluorouracil—colon cancer	0.000146	0.00442	CcSEcCtD
Teniposide—Flushing—Irinotecan—colon cancer	0.000141	0.00429	CcSEcCtD
Teniposide—Alopecia—Vincristine—colon cancer	0.000138	0.00419	CcSEcCtD
Teniposide—Chills—Irinotecan—colon cancer	0.000137	0.00414	CcSEcCtD
Teniposide—Neoplasm—Methotrexate—colon cancer	0.000137	0.00414	CcSEcCtD
Teniposide—Arrhythmia—Irinotecan—colon cancer	0.000136	0.00413	CcSEcCtD
Teniposide—Liver function test abnormal—Capecitabine—colon cancer	0.000136	0.00413	CcSEcCtD
Teniposide—CYP3A5—digestive system—colon cancer	0.000136	0.0142	CbGeAlD
Teniposide—ABCG2—bone marrow—colon cancer	0.000135	0.0141	CbGeAlD
Teniposide—Alopecia—Irinotecan—colon cancer	0.000135	0.00408	CcSEcCtD
Teniposide—CYP2C9—digestive system—colon cancer	0.000134	0.0139	CbGeAlD
Teniposide—Sepsis—Methotrexate—colon cancer	0.000131	0.00398	CcSEcCtD
Teniposide—Arrhythmia—Fluorouracil—colon cancer	0.00013	0.00395	CcSEcCtD
Teniposide—ABCG2—vagina—colon cancer	0.000129	0.0135	CbGeAlD
Teniposide—Alopecia—Fluorouracil—colon cancer	0.000129	0.00391	CcSEcCtD
Teniposide—CYP2C19—liver—colon cancer	0.000128	0.0134	CbGeAlD
Teniposide—Anaemia—Vincristine—colon cancer	0.000126	0.00382	CcSEcCtD
Teniposide—Bronchospasm—Capecitabine—colon cancer	0.000125	0.0038	CcSEcCtD
Teniposide—Agitation—Vincristine—colon cancer	0.000125	0.00379	CcSEcCtD
Teniposide—CYP3A4—renal system—colon cancer	0.000124	0.013	CbGeAlD
Teniposide—Anaemia—Irinotecan—colon cancer	0.000123	0.00372	CcSEcCtD
Teniposide—Leukopenia—Vincristine—colon cancer	0.000122	0.0037	CcSEcCtD
Teniposide—Pancytopenia—Capecitabine—colon cancer	0.000121	0.00367	CcSEcCtD
Teniposide—CYP3A5—vagina—colon cancer	0.00012	0.0125	CbGeAlD
Teniposide—Neutropenia—Capecitabine—colon cancer	0.000119	0.00361	CcSEcCtD
Teniposide—Leukopenia—Irinotecan—colon cancer	0.000119	0.0036	CcSEcCtD
Teniposide—Hypertension—Vincristine—colon cancer	0.000118	0.00356	CcSEcCtD
Teniposide—Anaemia—Fluorouracil—colon cancer	0.000117	0.00356	CcSEcCtD
Teniposide—TOP2A—Vindesine—Vincristine—colon cancer	0.000117	0.0733	CbGdCrCtD
Teniposide—Hypertension—Irinotecan—colon cancer	0.000115	0.00347	CcSEcCtD
Teniposide—Leukopenia—Fluorouracil—colon cancer	0.000114	0.00345	CcSEcCtD
Teniposide—Neuropathy peripheral—Capecitabine—colon cancer	0.000111	0.00338	CcSEcCtD
Teniposide—Oedema—Vincristine—colon cancer	0.000111	0.00337	CcSEcCtD
Teniposide—Stomatitis—Capecitabine—colon cancer	0.000111	0.00336	CcSEcCtD
Teniposide—Infection—Vincristine—colon cancer	0.00011	0.00335	CcSEcCtD
Teniposide—Confusional state—Irinotecan—colon cancer	0.000109	0.00331	CcSEcCtD
Teniposide—ABCG2—liver—colon cancer	0.000109	0.0114	CbGeAlD
Teniposide—Thrombocytopenia—Vincristine—colon cancer	0.000109	0.0033	CcSEcCtD
Teniposide—Oedema—Irinotecan—colon cancer	0.000108	0.00328	CcSEcCtD
Teniposide—Chest pain—Fluorouracil—colon cancer	0.000108	0.00328	CcSEcCtD
Teniposide—Infection—Irinotecan—colon cancer	0.000108	0.00326	CcSEcCtD
Teniposide—Hyperhidrosis—Vincristine—colon cancer	0.000108	0.00326	CcSEcCtD
Teniposide—Thrombocytopenia—Irinotecan—colon cancer	0.000106	0.00321	CcSEcCtD
Teniposide—Anorexia—Vincristine—colon cancer	0.000106	0.00321	CcSEcCtD
Teniposide—Hyperhidrosis—Irinotecan—colon cancer	0.000105	0.00317	CcSEcCtD
Teniposide—Confusional state—Fluorouracil—colon cancer	0.000105	0.00317	CcSEcCtD
Teniposide—Hypotension—Vincristine—colon cancer	0.000104	0.00315	CcSEcCtD
Teniposide—Oedema—Fluorouracil—colon cancer	0.000104	0.00314	CcSEcCtD
Teniposide—Anorexia—Irinotecan—colon cancer	0.000103	0.00313	CcSEcCtD
Teniposide—Infection—Fluorouracil—colon cancer	0.000103	0.00312	CcSEcCtD
Teniposide—Haemoglobin—Capecitabine—colon cancer	0.000103	0.00311	CcSEcCtD
Teniposide—Haemorrhage—Capecitabine—colon cancer	0.000102	0.00309	CcSEcCtD
Teniposide—CYP3A4—digestive system—colon cancer	0.000102	0.0106	CbGeAlD
Teniposide—Thrombocytopenia—Fluorouracil—colon cancer	0.000102	0.00308	CcSEcCtD
Teniposide—Liver function test abnormal—Methotrexate—colon cancer	0.000101	0.00307	CcSEcCtD
Teniposide—Tachycardia—Fluorouracil—colon cancer	0.000101	0.00307	CcSEcCtD
Teniposide—Hypotension—Irinotecan—colon cancer	0.000101	0.00307	CcSEcCtD
Teniposide—CYP3A5—liver—colon cancer	0.000101	0.0106	CbGeAlD
Teniposide—CYP2C9—liver—colon cancer	9.95e-05	0.0104	CbGeAlD
Teniposide—Anorexia—Fluorouracil—colon cancer	9.89e-05	0.003	CcSEcCtD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—CDH1—colon cancer	9.75e-05	0.00349	CbGpPWpGaD
Teniposide—CYP3A5—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	9.73e-05	0.00348	CbGpPWpGaD
Teniposide—Hypotension—Fluorouracil—colon cancer	9.69e-05	0.00294	CcSEcCtD
Teniposide—Decreased appetite—Vincristine—colon cancer	9.67e-05	0.00293	CcSEcCtD
Teniposide—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—ABCB1—colon cancer	9.66e-05	0.00345	CbGpPWpGaD
Teniposide—Dyspnoea—Irinotecan—colon cancer	9.66e-05	0.00293	CcSEcCtD
Teniposide—NCOA1—Validated nuclear estrogen receptor alpha network—MYC—colon cancer	9.58e-05	0.00343	CbGpPWpGaD
Teniposide—CYP3A4—Metapathway biotransformation—CHST4—colon cancer	9.58e-05	0.00342	CbGpPWpGaD
Teniposide—NCOA1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—colon cancer	9.57e-05	0.00342	CbGpPWpGaD
Teniposide—NCOA1—Adipogenesis—PPARG—colon cancer	9.54e-05	0.00341	CbGpPWpGaD
Teniposide—NCOA1—Transcriptional regulation of white adipocyte differentiation—EP300—colon cancer	9.49e-05	0.00339	CbGpPWpGaD
Teniposide—NCOA1—Glucocorticoid receptor regulatory network—CDKN1A—colon cancer	9.48e-05	0.00339	CbGpPWpGaD
Teniposide—Flushing—Capecitabine—colon cancer	9.47e-05	0.00287	CcSEcCtD
Teniposide—CYP3A5—Metapathway biotransformation—CHST5—colon cancer	9.46e-05	0.00338	CbGpPWpGaD
Teniposide—NCOA1—Leptin signaling pathway—SRC—colon cancer	9.42e-05	0.00337	CbGpPWpGaD
Teniposide—Decreased appetite—Irinotecan—colon cancer	9.42e-05	0.00285	CcSEcCtD
Teniposide—NCOA3—EGF/EGFR Signaling Pathway—BRAF—colon cancer	9.42e-05	0.00337	CbGpPWpGaD
Teniposide—Dyspnoea—Fluorouracil—colon cancer	9.25e-05	0.0028	CcSEcCtD
Teniposide—NCOA1—Androgen receptor signaling pathway—CCND1—colon cancer	9.18e-05	0.00328	CbGpPWpGaD
Teniposide—Chills—Capecitabine—colon cancer	9.16e-05	0.00277	CcSEcCtD
Teniposide—NCOA1—IL-6 signaling pathway—AKT1—colon cancer	9.14e-05	0.00327	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—HNF4A—colon cancer	9.13e-05	0.00326	CbGpPWpGaD
Teniposide—Arrhythmia—Capecitabine—colon cancer	9.12e-05	0.00276	CcSEcCtD
Teniposide—NCOA1—Regulation of nuclear SMAD2/3 signaling—EP300—colon cancer	9.11e-05	0.00326	CbGpPWpGaD
Teniposide—Gastrointestinal pain—Vincristine—colon cancer	9.09e-05	0.00276	CcSEcCtD
Teniposide—NCOA1—Androgen receptor signaling pathway—CTNNB1—colon cancer	9.09e-05	0.00325	CbGpPWpGaD
Teniposide—TOP2A—Gastric Cancer Network 2—MYC—colon cancer	9.07e-05	0.00324	CbGpPWpGaD
Teniposide—NCOA1—Glucocorticoid receptor regulatory network—EP300—colon cancer	9.02e-05	0.00322	CbGpPWpGaD
Teniposide—Decreased appetite—Fluorouracil—colon cancer	9.02e-05	0.00273	CcSEcCtD
Teniposide—Alopecia—Capecitabine—colon cancer	9.02e-05	0.00273	CcSEcCtD
Teniposide—Pancytopenia—Methotrexate—colon cancer	9.01e-05	0.00273	CcSEcCtD
Teniposide—NCOA1—Developmental Biology—DCC—colon cancer	8.97e-05	0.00321	CbGpPWpGaD
Teniposide—Feeling abnormal—Irinotecan—colon cancer	8.93e-05	0.0027	CcSEcCtD
Teniposide—NCOA3—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—colon cancer	8.89e-05	0.00318	CbGpPWpGaD
Teniposide—NCOA1—Androgen receptor signaling pathway—CDKN1A—colon cancer	8.88e-05	0.00317	CbGpPWpGaD
Teniposide—Neutropenia—Methotrexate—colon cancer	8.87e-05	0.00269	CcSEcCtD
Teniposide—TOP2A—Gastric Cancer Network 2—EGFR—colon cancer	8.87e-05	0.00317	CbGpPWpGaD
Teniposide—Gastrointestinal pain—Irinotecan—colon cancer	8.86e-05	0.00268	CcSEcCtD
Teniposide—Abdominal pain—Vincristine—colon cancer	8.79e-05	0.00266	CcSEcCtD
Teniposide—Body temperature increased—Vincristine—colon cancer	8.79e-05	0.00266	CcSEcCtD
Teniposide—NCOA3—Androgen receptor signaling pathway—EGFR—colon cancer	8.71e-05	0.00311	CbGpPWpGaD
Teniposide—NCOA3—PPARA activates gene expression—EP300—colon cancer	8.62e-05	0.00308	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—CHST5—colon cancer	8.57e-05	0.00306	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—ODC1—colon cancer	8.57e-05	0.00306	CbGpPWpGaD
Teniposide—Abdominal pain—Irinotecan—colon cancer	8.56e-05	0.00259	CcSEcCtD
Teniposide—Body temperature increased—Irinotecan—colon cancer	8.56e-05	0.00259	CcSEcCtD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	8.56e-05	0.00306	CbGpPWpGaD
Teniposide—Feeling abnormal—Fluorouracil—colon cancer	8.55e-05	0.00259	CcSEcCtD
Teniposide—NCOA1—Androgen receptor signaling pathway—EP300—colon cancer	8.45e-05	0.00302	CbGpPWpGaD
Teniposide—NCOA3—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—colon cancer	8.44e-05	0.00302	CbGpPWpGaD
Teniposide—ABCG2—lymph node—colon cancer	8.35e-05	0.00872	CbGeAlD
Teniposide—Stomatitis—Methotrexate—colon cancer	8.25e-05	0.0025	CcSEcCtD
Teniposide—NCOA1—Transcriptional regulation of white adipocyte differentiation—TGFB1—colon cancer	8.25e-05	0.00295	CbGpPWpGaD
Teniposide—Urticaria—Fluorouracil—colon cancer	8.24e-05	0.0025	CcSEcCtD
Teniposide—NCOA1—Androgen receptor signaling pathway—SRC—colon cancer	8.21e-05	0.00294	CbGpPWpGaD
Teniposide—Anaemia—Capecitabine—colon cancer	8.21e-05	0.00249	CcSEcCtD
Teniposide—Body temperature increased—Fluorouracil—colon cancer	8.2e-05	0.00248	CcSEcCtD
Teniposide—Hypersensitivity—Vincristine—colon cancer	8.19e-05	0.00248	CcSEcCtD
Teniposide—Sweating—Methotrexate—colon cancer	8.11e-05	0.00246	CcSEcCtD
Teniposide—NCOA1—Generic Transcription Pathway—HNF4A—colon cancer	8.02e-05	0.00287	CbGpPWpGaD
Teniposide—Hypersensitivity—Irinotecan—colon cancer	7.98e-05	0.00242	CcSEcCtD
Teniposide—Asthenia—Vincristine—colon cancer	7.98e-05	0.00242	CcSEcCtD
Teniposide—Leukopenia—Capecitabine—colon cancer	7.95e-05	0.00241	CcSEcCtD
Teniposide—NCOA1—Regulation of nuclear SMAD2/3 signaling—MYC—colon cancer	7.94e-05	0.00284	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—MLH3—colon cancer	7.91e-05	0.00283	CbGpPWpGaD
Teniposide—Asthenia—Irinotecan—colon cancer	7.77e-05	0.00235	CcSEcCtD
Teniposide—Hypertension—Capecitabine—colon cancer	7.67e-05	0.00232	CcSEcCtD
Teniposide—Hypersensitivity—Fluorouracil—colon cancer	7.64e-05	0.00232	CcSEcCtD
Teniposide—Haemoglobin—Methotrexate—colon cancer	7.63e-05	0.00231	CcSEcCtD
Teniposide—ABCG2—HIF-1-alpha transcription factor network—ABCB1—colon cancer	7.61e-05	0.00272	CbGpPWpGaD
Teniposide—Diarrhoea—Vincristine—colon cancer	7.61e-05	0.00231	CcSEcCtD
Teniposide—Haemorrhage—Methotrexate—colon cancer	7.6e-05	0.0023	CcSEcCtD
Teniposide—CYP3A4—liver—colon cancer	7.59e-05	0.00792	CbGeAlD
Teniposide—Chest pain—Capecitabine—colon cancer	7.56e-05	0.00229	CcSEcCtD
Teniposide—NCOA1—Developmental Biology—HNF4A—colon cancer	7.55e-05	0.0027	CbGpPWpGaD
Teniposide—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	7.52e-05	0.00269	CbGpPWpGaD
Teniposide—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	7.5e-05	0.00268	CbGpPWpGaD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—CASP3—colon cancer	7.47e-05	0.00267	CbGpPWpGaD
Teniposide—TOP2A—Gastric Cancer Network 2—TP53—colon cancer	7.45e-05	0.00266	CbGpPWpGaD
Teniposide—Diarrhoea—Irinotecan—colon cancer	7.41e-05	0.00225	CcSEcCtD
Teniposide—TOP2A—Vinorelbine—Vincristine—colon cancer	7.41e-05	0.0462	CbGdCrCtD
Teniposide—NCOA1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—colon cancer	7.35e-05	0.00263	CbGpPWpGaD
Teniposide—Pruritus—Fluorouracil—colon cancer	7.34e-05	0.00222	CcSEcCtD
Teniposide—CYP2C19—Metapathway biotransformation—CHST5—colon cancer	7.31e-05	0.00261	CbGpPWpGaD
Teniposide—Confusional state—Capecitabine—colon cancer	7.31e-05	0.00221	CcSEcCtD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—CCND1—colon cancer	7.27e-05	0.0026	CbGpPWpGaD
Teniposide—Oedema—Capecitabine—colon cancer	7.25e-05	0.0022	CcSEcCtD
Teniposide—Infection—Capecitabine—colon cancer	7.2e-05	0.00218	CcSEcCtD
Teniposide—NCOA1—Androgen receptor signaling pathway—EGFR—colon cancer	7.2e-05	0.00257	CbGpPWpGaD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—CTNNB1—colon cancer	7.2e-05	0.00257	CbGpPWpGaD
Teniposide—NCOA1—PPARA activates gene expression—EP300—colon cancer	7.13e-05	0.00255	CbGpPWpGaD
Teniposide—Diarrhoea—Fluorouracil—colon cancer	7.1e-05	0.00215	CcSEcCtD
Teniposide—Thrombocytopenia—Capecitabine—colon cancer	7.1e-05	0.00215	CcSEcCtD
Teniposide—NCOA1—Metabolism—CHST5—colon cancer	7.09e-05	0.00253	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—ODC1—colon cancer	7.09e-05	0.00253	CbGpPWpGaD
Teniposide—Tachycardia—Capecitabine—colon cancer	7.08e-05	0.00214	CcSEcCtD
Teniposide—Vomiting—Vincristine—colon cancer	7.07e-05	0.00214	CcSEcCtD
Teniposide—Rash—Vincristine—colon cancer	7.01e-05	0.00212	CcSEcCtD
Teniposide—Hyperhidrosis—Capecitabine—colon cancer	7.01e-05	0.00212	CcSEcCtD
Teniposide—Dermatitis—Vincristine—colon cancer	7.01e-05	0.00212	CcSEcCtD
Teniposide—NCOA1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—colon cancer	6.98e-05	0.00249	CbGpPWpGaD
Teniposide—Headache—Vincristine—colon cancer	6.97e-05	0.00211	CcSEcCtD
Teniposide—TOP2A—Mitotic G1-G1/S phases—TYMS—colon cancer	6.92e-05	0.00247	CbGpPWpGaD
Teniposide—Anorexia—Capecitabine—colon cancer	6.91e-05	0.00209	CcSEcCtD
Teniposide—Vomiting—Irinotecan—colon cancer	6.89e-05	0.00209	CcSEcCtD
Teniposide—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	6.86e-05	0.00245	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	6.84e-05	0.00245	CbGpPWpGaD
Teniposide—Rash—Irinotecan—colon cancer	6.83e-05	0.00207	CcSEcCtD
Teniposide—Dermatitis—Irinotecan—colon cancer	6.82e-05	0.00207	CcSEcCtD
Teniposide—Chills—Methotrexate—colon cancer	6.82e-05	0.00206	CcSEcCtD
Teniposide—Headache—Irinotecan—colon cancer	6.79e-05	0.00206	CcSEcCtD
Teniposide—Hypotension—Capecitabine—colon cancer	6.77e-05	0.00205	CcSEcCtD
Teniposide—Alopecia—Methotrexate—colon cancer	6.71e-05	0.00203	CcSEcCtD
Teniposide—NCOA1—Adipogenesis—CTNNB1—colon cancer	6.71e-05	0.0024	CbGpPWpGaD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—EP300—colon cancer	6.69e-05	0.00239	CbGpPWpGaD
Teniposide—CYP2C9—Metapathway biotransformation—CHST5—colon cancer	6.67e-05	0.00238	CbGpPWpGaD
Teniposide—NCOA1—Leptin signaling pathway—HRAS—colon cancer	6.63e-05	0.00237	CbGpPWpGaD
Teniposide—Nausea—Vincristine—colon cancer	6.61e-05	0.002	CcSEcCtD
Teniposide—Vomiting—Fluorouracil—colon cancer	6.6e-05	0.002	CcSEcCtD
Teniposide—NCOA1—Adipogenesis—CDKN1A—colon cancer	6.56e-05	0.00234	CbGpPWpGaD
Teniposide—Rash—Fluorouracil—colon cancer	6.54e-05	0.00198	CcSEcCtD
Teniposide—Dermatitis—Fluorouracil—colon cancer	6.53e-05	0.00198	CcSEcCtD
Teniposide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	6.53e-05	0.00234	CbGpPWpGaD
Teniposide—Headache—Fluorouracil—colon cancer	6.5e-05	0.00197	CcSEcCtD
Teniposide—NCOA1—HIF-1-alpha transcription factor network—AKT1—colon cancer	6.48e-05	0.00232	CbGpPWpGaD
Teniposide—Dyspnoea—Capecitabine—colon cancer	6.46e-05	0.00196	CcSEcCtD
Teniposide—NCOA1—Glucocorticoid receptor regulatory network—TP53—colon cancer	6.45e-05	0.00231	CbGpPWpGaD
Teniposide—Nausea—Irinotecan—colon cancer	6.43e-05	0.00195	CcSEcCtD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—VEGFA—colon cancer	6.34e-05	0.00227	CbGpPWpGaD
Teniposide—CYP3A4—Irinotecan Pathway—APC—colon cancer	6.32e-05	0.00226	CbGpPWpGaD
Teniposide—Decreased appetite—Capecitabine—colon cancer	6.3e-05	0.00191	CcSEcCtD
Teniposide—NCOA3—Androgen receptor signaling pathway—AKT1—colon cancer	6.17e-05	0.00221	CbGpPWpGaD
Teniposide—Nausea—Fluorouracil—colon cancer	6.16e-05	0.00187	CcSEcCtD
Teniposide—NCOA3—EGF/EGFR Signaling Pathway—SRC—colon cancer	6.15e-05	0.0022	CbGpPWpGaD
Teniposide—Anaemia—Methotrexate—colon cancer	6.11e-05	0.00185	CcSEcCtD
Teniposide—Feeling abnormal—Capecitabine—colon cancer	5.97e-05	0.00181	CcSEcCtD
Teniposide—Gastrointestinal pain—Capecitabine—colon cancer	5.93e-05	0.0018	CcSEcCtD
Teniposide—Leukopenia—Methotrexate—colon cancer	5.92e-05	0.00179	CcSEcCtD
Teniposide—ABCG2—HIF-2-alpha transcription factor network—EP300—colon cancer	5.89e-05	0.00211	CbGpPWpGaD
Teniposide—NCOA1—Leptin signaling pathway—AKT1—colon cancer	5.85e-05	0.00209	CbGpPWpGaD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—MYC—colon cancer	5.83e-05	0.00208	CbGpPWpGaD
Teniposide—NCOA3—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—colon cancer	5.81e-05	0.00208	CbGpPWpGaD
Teniposide—Urticaria—Capecitabine—colon cancer	5.76e-05	0.00174	CcSEcCtD
Teniposide—Body temperature increased—Capecitabine—colon cancer	5.73e-05	0.00174	CcSEcCtD
Teniposide—Abdominal pain—Capecitabine—colon cancer	5.73e-05	0.00174	CcSEcCtD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—EGFR—colon cancer	5.7e-05	0.00204	CbGpPWpGaD
Teniposide—Chest pain—Methotrexate—colon cancer	5.63e-05	0.00171	CcSEcCtD
Teniposide—ABCG2—HIF-2-alpha transcription factor network—VEGFA—colon cancer	5.58e-05	0.00199	CbGpPWpGaD
Teniposide—ABCC6—Transmembrane transport of small molecules—ABCB1—colon cancer	5.53e-05	0.00198	CbGpPWpGaD
Teniposide—NCOA1—Regulation of nuclear SMAD2/3 signaling—AKT1—colon cancer	5.5e-05	0.00197	CbGpPWpGaD
Teniposide—NCOA1—Glucocorticoid receptor regulatory network—AKT1—colon cancer	5.45e-05	0.00195	CbGpPWpGaD
Teniposide—Confusional state—Methotrexate—colon cancer	5.44e-05	0.00165	CcSEcCtD
Teniposide—NCOA1—Adipogenesis—TGFB1—colon cancer	5.42e-05	0.00194	CbGpPWpGaD
Teniposide—NCOA3—EGF/EGFR Signaling Pathway—EGFR—colon cancer	5.39e-05	0.00193	CbGpPWpGaD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—KRAS—colon cancer	5.39e-05	0.00193	CbGpPWpGaD
Teniposide—Infection—Methotrexate—colon cancer	5.36e-05	0.00162	CcSEcCtD
Teniposide—Hypersensitivity—Capecitabine—colon cancer	5.34e-05	0.00162	CcSEcCtD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—ABCB1—colon cancer	5.34e-05	0.00191	CbGpPWpGaD
Teniposide—Thrombocytopenia—Methotrexate—colon cancer	5.28e-05	0.0016	CcSEcCtD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	5.24e-05	0.00187	CbGpPWpGaD
Teniposide—Hyperhidrosis—Methotrexate—colon cancer	5.22e-05	0.00158	CcSEcCtD
Teniposide—Asthenia—Capecitabine—colon cancer	5.2e-05	0.00158	CcSEcCtD
Teniposide—Anorexia—Methotrexate—colon cancer	5.14e-05	0.00156	CcSEcCtD
Teniposide—Pruritus—Capecitabine—colon cancer	5.13e-05	0.00155	CcSEcCtD
Teniposide—NCOA1—Androgen receptor signaling pathway—AKT1—colon cancer	5.11e-05	0.00182	CbGpPWpGaD
Teniposide—TOP2A—Vinblastine—Vincristine—colon cancer	5.09e-05	0.0318	CbGdCrCtD
Teniposide—NCOA3—EGF/EGFR Signaling Pathway—KRAS—colon cancer	5.09e-05	0.00182	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	5.05e-05	0.00181	CbGpPWpGaD
Teniposide—Hypotension—Methotrexate—colon cancer	5.04e-05	0.00153	CcSEcCtD
Teniposide—TOP2A—Circadian rythm related genes—TYMS—colon cancer	5.03e-05	0.0018	CbGpPWpGaD
Teniposide—Diarrhoea—Capecitabine—colon cancer	4.96e-05	0.0015	CcSEcCtD
Teniposide—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—colon cancer	4.95e-05	0.00177	CbGpPWpGaD
Teniposide—Dyspnoea—Methotrexate—colon cancer	4.81e-05	0.00146	CcSEcCtD
Teniposide—NCOA1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—colon cancer	4.81e-05	0.00172	CbGpPWpGaD
Teniposide—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1A—colon cancer	4.79e-05	0.00171	CbGpPWpGaD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—TP53—colon cancer	4.79e-05	0.00171	CbGpPWpGaD
Teniposide—Decreased appetite—Methotrexate—colon cancer	4.69e-05	0.00142	CcSEcCtD
Teniposide—Vomiting—Capecitabine—colon cancer	4.61e-05	0.0014	CcSEcCtD
Teniposide—Rash—Capecitabine—colon cancer	4.57e-05	0.00138	CcSEcCtD
Teniposide—Dermatitis—Capecitabine—colon cancer	4.57e-05	0.00138	CcSEcCtD
Teniposide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	4.55e-05	0.00163	CbGpPWpGaD
Teniposide—Headache—Capecitabine—colon cancer	4.54e-05	0.00138	CcSEcCtD
Teniposide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	4.52e-05	0.00162	CbGpPWpGaD
Teniposide—Feeling abnormal—Methotrexate—colon cancer	4.45e-05	0.00135	CcSEcCtD
Teniposide—Gastrointestinal pain—Methotrexate—colon cancer	4.41e-05	0.00134	CcSEcCtD
Teniposide—CYP3A4—Metapathway biotransformation—CHST5—colon cancer	4.4e-05	0.00157	CbGpPWpGaD
Teniposide—NCOA3—EGF/EGFR Signaling Pathway—HRAS—colon cancer	4.33e-05	0.00155	CbGpPWpGaD
Teniposide—ABCG2—Fluoropyrimidine Activity—TP53—colon cancer	4.32e-05	0.00154	CbGpPWpGaD
Teniposide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	4.31e-05	0.00154	CbGpPWpGaD
Teniposide—Nausea—Capecitabine—colon cancer	4.31e-05	0.0013	CcSEcCtD
Teniposide—Urticaria—Methotrexate—colon cancer	4.29e-05	0.0013	CcSEcCtD
Teniposide—Abdominal pain—Methotrexate—colon cancer	4.27e-05	0.00129	CcSEcCtD
Teniposide—Body temperature increased—Methotrexate—colon cancer	4.27e-05	0.00129	CcSEcCtD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—AKT1—colon cancer	4.04e-05	0.00145	CbGpPWpGaD
Teniposide—NCOA1—Transmembrane transport of small molecules—ABCB1—colon cancer	4e-05	0.00143	CbGpPWpGaD
Teniposide—Hypersensitivity—Methotrexate—colon cancer	3.98e-05	0.0012	CcSEcCtD
Teniposide—TOP2A—Retinoblastoma (RB) in Cancer—MYC—colon cancer	3.97e-05	0.00142	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—PPARG—colon cancer	3.96e-05	0.00142	CbGpPWpGaD
Teniposide—Asthenia—Methotrexate—colon cancer	3.87e-05	0.00117	CcSEcCtD
Teniposide—NCOA1—Gene Expression—HNF4A—colon cancer	3.86e-05	0.00138	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—APC—colon cancer	3.85e-05	0.00138	CbGpPWpGaD
Teniposide—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	3.83e-05	0.00137	CbGpPWpGaD
Teniposide—NCOA3—EGF/EGFR Signaling Pathway—AKT1—colon cancer	3.82e-05	0.00137	CbGpPWpGaD
Teniposide—Pruritus—Methotrexate—colon cancer	3.82e-05	0.00116	CcSEcCtD
Teniposide—ABCG2—Metabolism—CA7—colon cancer	3.78e-05	0.00135	CbGpPWpGaD
Teniposide—Diarrhoea—Methotrexate—colon cancer	3.69e-05	0.00112	CcSEcCtD
Teniposide—TOP2A—Circadian rythm related genes—PPARG—colon cancer	3.57e-05	0.00127	CbGpPWpGaD
Teniposide—NCOA3—Metabolism of lipids and lipoproteins—PPARG—colon cancer	3.54e-05	0.00126	CbGpPWpGaD
Teniposide—TOP2A—Mitotic G1-G1/S phases—CCND1—colon cancer	3.49e-05	0.00125	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—MLH1—colon cancer	3.48e-05	0.00124	CbGpPWpGaD
Teniposide—NCOA1—Generic Transcription Pathway—PPARG—colon cancer	3.48e-05	0.00124	CbGpPWpGaD
Teniposide—ABCG2—HIF-1-alpha transcription factor network—EP300—colon cancer	3.46e-05	0.00124	CbGpPWpGaD
Teniposide—Vomiting—Methotrexate—colon cancer	3.43e-05	0.00104	CcSEcCtD
Teniposide—Rash—Methotrexate—colon cancer	3.4e-05	0.00103	CcSEcCtD
Teniposide—Dermatitis—Methotrexate—colon cancer	3.4e-05	0.00103	CcSEcCtD
Teniposide—Headache—Methotrexate—colon cancer	3.38e-05	0.00102	CcSEcCtD
Teniposide—TOP2A—Mitotic G1-G1/S phases—CDKN1A—colon cancer	3.37e-05	0.00121	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—BUB1B—colon cancer	3.31e-05	0.00118	CbGpPWpGaD
Teniposide—ABCG2—HIF-1-alpha transcription factor network—VEGFA—colon cancer	3.28e-05	0.00117	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—PPARG—colon cancer	3.28e-05	0.00117	CbGpPWpGaD
Teniposide—TOP2A—Retinoblastoma (RB) in Cancer—TP53—colon cancer	3.26e-05	0.00117	CbGpPWpGaD
Teniposide—Nausea—Methotrexate—colon cancer	3.21e-05	0.000971	CcSEcCtD
Teniposide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	3e-05	0.00107	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—BUB1B—colon cancer	2.96e-05	0.00106	CbGpPWpGaD
Teniposide—NCOA1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	2.93e-05	0.00105	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	2.92e-05	0.00104	CbGpPWpGaD
Teniposide—CYP2C19—Arachidonic acid metabolism—PTGS2—colon cancer	2.88e-05	0.00103	CbGpPWpGaD
Teniposide—TOP2A—Mitotic G1-G1/S phases—MYC—colon cancer	2.8e-05	0.000999	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—CTNNB1—colon cancer	2.79e-05	0.000997	CbGpPWpGaD
Teniposide—NCOA3—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	2.78e-05	0.000995	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	2.71e-05	0.00097	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—CA7—colon cancer	2.71e-05	0.000968	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	2.64e-05	0.000944	CbGpPWpGaD
Teniposide—CYP2C9—Arachidonic acid metabolism—PTGS2—colon cancer	2.63e-05	0.000939	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	2.62e-05	0.000935	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—EP300—colon cancer	2.59e-05	0.000927	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	2.55e-05	0.000913	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—TYMS—colon cancer	2.54e-05	0.000908	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—SRC—colon cancer	2.52e-05	0.000901	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—VEGFA—colon cancer	2.46e-05	0.000878	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	2.43e-05	0.000869	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—NRAS—colon cancer	2.43e-05	0.000867	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	2.36e-05	0.000845	CbGpPWpGaD
Teniposide—TOP2A—Circadian rythm related genes—EP300—colon cancer	2.33e-05	0.000834	CbGpPWpGaD
Teniposide—NCOA3—Metabolism of lipids and lipoproteins—EP300—colon cancer	2.32e-05	0.000828	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—CTNNB1—colon cancer	2.31e-05	0.000825	CbGpPWpGaD
Teniposide—NCOA1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	2.3e-05	0.000823	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	2.3e-05	0.000823	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—CHST5—colon cancer	2.29e-05	0.000818	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—ODC1—colon cancer	2.29e-05	0.000818	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—TYMS—colon cancer	2.27e-05	0.000812	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—ABCB1—colon cancer	2.27e-05	0.00081	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—TGFB1—colon cancer	2.25e-05	0.000806	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—TYMS—colon cancer	2.22e-05	0.000795	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—EGFR—colon cancer	2.21e-05	0.00079	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—EP300—colon cancer	2.14e-05	0.000766	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	2.12e-05	0.000757	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	2.11e-05	0.000755	CbGpPWpGaD
Teniposide—ABCG2—HIF-1-alpha transcription factor network—AKT1—colon cancer	2.09e-05	0.000748	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—CA7—colon cancer	2.09e-05	0.000748	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—KRAS—colon cancer	2.09e-05	0.000746	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—SRC—colon cancer	2.09e-05	0.000745	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	2.07e-05	0.000741	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—VEGFA—colon cancer	2.03e-05	0.000726	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—NRAS—colon cancer	2.01e-05	0.000717	CbGpPWpGaD
Teniposide—NCOA1—Generic Transcription Pathway—MYC—colon cancer	1.99e-05	0.00071	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	1.96e-05	0.0007	CbGpPWpGaD
Teniposide—NCOA1—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.91e-05	0.000685	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—CA7—colon cancer	1.91e-05	0.000682	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—ABCB1—colon cancer	1.87e-05	0.00067	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—TGFB1—colon cancer	1.86e-05	0.000666	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—TYMS—colon cancer	1.84e-05	0.000658	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—EGFR—colon cancer	1.83e-05	0.000653	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	1.8e-05	0.000643	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—HRAS—colon cancer	1.77e-05	0.000634	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	1.74e-05	0.000622	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—KRAS—colon cancer	1.73e-05	0.000617	CbGpPWpGaD
Teniposide—NCOA3—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.71e-05	0.000612	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—PPARG—colon cancer	1.68e-05	0.000599	CbGpPWpGaD
Teniposide—TOP2A—Circadian rythm related genes—TP53—colon cancer	1.67e-05	0.000597	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—CHST5—colon cancer	1.64e-05	0.000586	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—ODC1—colon cancer	1.64e-05	0.000586	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—PPARG—colon cancer	1.58e-05	0.000563	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—AKT1—colon cancer	1.57e-05	0.00056	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	1.47e-05	0.000525	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—HRAS—colon cancer	1.47e-05	0.000525	CbGpPWpGaD
Teniposide—NCOA1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.42e-05	0.000506	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—PPARG—colon cancer	1.3e-05	0.000466	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—AKT1—colon cancer	1.3e-05	0.000463	CbGpPWpGaD
Teniposide—ABCG2—Transmembrane transport of small molecules—ABCB1—colon cancer	1.29e-05	0.000462	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—CCND1—colon cancer	1.28e-05	0.000457	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—CHST5—colon cancer	1.27e-05	0.000453	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—ODC1—colon cancer	1.27e-05	0.000453	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—CA7—colon cancer	1.26e-05	0.00045	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—PTGS2—colon cancer	1.24e-05	0.000443	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—CDKN1A—colon cancer	1.24e-05	0.000442	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—EP300—colon cancer	1.18e-05	0.000421	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—ODC1—colon cancer	1.16e-05	0.000413	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—CHST5—colon cancer	1.16e-05	0.000413	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—CCND1—colon cancer	1.14e-05	0.000409	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—CDKN1A—colon cancer	1.11e-05	0.000395	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—EP300—colon cancer	1.05e-05	0.000376	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—EP300—colon cancer	1.03e-05	0.000369	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—PTGS2—colon cancer	1.03e-05	0.000367	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—MYC—colon cancer	1.03e-05	0.000367	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—MYC—colon cancer	9.56e-06	0.000342	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—MYC—colon cancer	9.17e-06	0.000328	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—EP300—colon cancer	8.53e-06	0.000305	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—PIK3CA—colon cancer	7.63e-06	0.000273	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—ODC1—colon cancer	7.62e-06	0.000273	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—CHST5—colon cancer	7.62e-06	0.000273	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—TP53—colon cancer	7.53e-06	0.000269	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—AKT1—colon cancer	6.63e-06	0.000237	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—PIK3CA—colon cancer	6.31e-06	0.000226	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—AKT1—colon cancer	6.23e-06	0.000223	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—ABCB1—colon cancer	6.05e-06	0.000216	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—TYMS—colon cancer	5.94e-06	0.000212	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—colon cancer	5.23e-06	0.000187	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—AKT1—colon cancer	5.15e-06	0.000184	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	4.77e-06	0.000171	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—ABCB1—colon cancer	4.33e-06	0.000155	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—TYMS—colon cancer	4.26e-06	0.000152	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—PPARG—colon cancer	4.21e-06	0.00015	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	4.12e-06	0.000147	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	3.75e-06	0.000134	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.42e-06	0.000122	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—ABCB1—colon cancer	3.35e-06	0.00012	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—PTGS2—colon cancer	3.31e-06	0.000118	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—TYMS—colon cancer	3.29e-06	0.000118	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.12e-06	0.000112	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—ABCB1—colon cancer	3.05e-06	0.000109	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—PPARG—colon cancer	3.02e-06	0.000108	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—TYMS—colon cancer	3e-06	0.000107	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—EP300—colon cancer	2.75e-06	9.84e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.53e-06	9.05e-05	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—PTGS2—colon cancer	2.37e-06	8.48e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—PPARG—colon cancer	2.33e-06	8.33e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.31e-06	8.26e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—PPARG—colon cancer	2.13e-06	7.6e-05	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—PIK3CA—colon cancer	2.04e-06	7.28e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—ABCB1—colon cancer	2.01e-06	7.2e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—TYMS—colon cancer	1.98e-06	7.07e-05	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—EP300—colon cancer	1.97e-06	7.05e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—PTGS2—colon cancer	1.83e-06	6.55e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—PTGS2—colon cancer	1.67e-06	5.98e-05	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—AKT1—colon cancer	1.66e-06	5.95e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—EP300—colon cancer	1.53e-06	5.45e-05	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—PIK3CA—colon cancer	1.46e-06	5.22e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—PPARG—colon cancer	1.4e-06	5.01e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—EP300—colon cancer	1.39e-06	4.97e-05	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—AKT1—colon cancer	1.19e-06	4.26e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—PIK3CA—colon cancer	1.13e-06	4.03e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—PTGS2—colon cancer	1.1e-06	3.94e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—PIK3CA—colon cancer	1.03e-06	3.68e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—AKT1—colon cancer	9.22e-07	3.29e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—EP300—colon cancer	9.17e-07	3.28e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—AKT1—colon cancer	8.4e-07	3e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—PIK3CA—colon cancer	6.78e-07	2.42e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—AKT1—colon cancer	5.54e-07	1.98e-05	CbGpPWpGaD
